Use of antimigraine medication before pregnancy and in the first trimester: A cross-sectional study.

ABSTRACT:

Objectives/background

Migraine is common among women, particularly during their reproductive years. There is limited research on the use of antimigraine medication before and during pregnancy. This study was undertaken to describe the use of antimigraine medication 3 months before pregnancy and in the first trimester among women with migraine and to evaluate maternal characteristics associated with continued use in the first trimester.

Methods

In this cross-sectional study, we used patient-reported data from the Copenhagen Pregnancy Cohort from October 2013 to May 2019 and included all women with migraine before pregnancy. The use of antimigraine medication before pregnancy and during the first trimester was assessed descriptively.

Results

Among women with migraine (N

SUBMITTER: Wieland S 

PROVIDER: S-EPMC12638518 | biostudies-literature | 2025 Nov-Dec

REPOSITORIES: biostudies-literature